Press release
North America and Europe PEGylated Drugs Market 2018-2024| Key Players: Pfizer, Amgen, Biogen, Novo Nordisk
North America and Europe PEGylated Drugs Market
Growing biologics sector such as, new advances in cell therapies, immunotherapies, antibody drug conjugates, gene therapies will offer immense growth opportunities in the future. Increasing acceptance of biologics drugs such as, monoclonal antibodies, colony stimulating factors, and interferons for treatment of chronic diseases will upsurge revenue share of PEGylated drugs in developed regions. However, drug recalls and adverse drug reactions associated with pegylated drugs will hinder business growth during the forecast timeframe.
Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/2511
Cancer accounted for over 60% of the industry share in 2017. This is attributable to increasing prevalence of cancer along with advancements in the field of cancer research. Increasing usage of advanced drug delivery systems with PEGylation technology is significant in the field of anti-cancer therapy due to ability of PEGylation to enhance retention time of therapeutics. Launch of Neulasta Onpro Kit in the U.S. for self-administration of Neulasta drug at homecare settings post chemotherapy is another major factor boosting segmental revenue size.
Gastrointestinal disorders will witness 19% growth over the forecast period owing to increasing adoption of pegylated drugs for treatment of gastrointestinal diseases. Launch and approval of pegylated drug such as Movantik used for the treatment of opioid-induced constipation (OIC) in adult patients will foster segmental growth.
Company profiled in this report based on Business overview, Financial data, Product landscape, Strategic outlook & SWOT analysis:
• Roche
• AstraZeneca
• Pfizer
• Amgen
• Biogen
• Novo Nordisk
• UCB
• Merck KGaA
However, the side-effects associated with pegylated drugs along with drug failure will impede PEGylated drugs market growth over the forecast timeframe. Cancer segment held over 60% of the overall market share in 2017 due to growing prevalence of the disease creating a demand for the development of effective drugs. Benefits offered by PEGylated drugs such as reduced proteolytic degradation along with minimized immunogenicity leading to enhanced therapeutic efficacy will propel market growth. Increasing areas of applications as well as rising adoption of PEGylated drugs to treat various types of cancer will stimulate business growth.
Hepatitis segment size was USD 156 million in 2017 and is anticipated to follow a declining trend over the forecast period. However, increasing focus of industry players to develop pegylated drugs used for the treatment of such chronic conditions will contribute to market growth. For instance, launch of Pegasys drug used for treating Hepatitis C in adult patients will fuel market growth. Monoclonal antibodies are anticipated to witness over 12% CAGR over the coming years due to its wide-ranging applications such as, anti-PEG antibodies are used to quantitate numerous PEGylated compounds. Additionally, anti-PEG antibodies can be combined with compound specific to antibody to generate specific and sensitive assays.
Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/2511
Canada PEGylated drugs market will witness over 5.5% CAGR from 2018 to 2024. Increasing prevalence of chronic ailments such as cancer will drive the North America and Europe PEGylated Drugs Market growth. As per Canadian Cancer Society, more than two lac people are diagnosed with cancer in 2017 that will surge demand for pegylated drugs in the future. Development and availability of various pegylated drugs including Onivyde, Plegridy, Oncaspar and others for treatment of several chronic ailments are factors accelerating business growth over the forecast timeframe.
Few notable industry players operating in North America and Europe PEGylated drugs market are Shire Group, UCB, Merck, AstraZeneca, Amgen, Sigma Tau, Biogen, Pfizer and Roche. Industry players attempt to develop enhanced and effective PEGylated drugs for treating chronic conditions. Robust pipeline and ongoing research studies coupled with high R&D investment in PEGylation technology is anticipated to propel industry growth.
Chapter 1. Methodology
1.1. Methodology
1.1.1. Methodology
1.1.2. Market definition
1.1.3. Forecast parameters
1.1.4. Data sources
1.1.4.1. Primary
1.1.4.2. Secondary
Chapter 2. Executive Summary
2.1. North America & Europe PEGylated drugs industry 3600 synopsis, 2013 - 2024 (USD Million)
2.1.1. Business trends
2.1.2. Disease indication trends
2.1.3. Type trends
2.1.4. Regional trends
Browse Full Report@ https://www.gminsights.com/industry-analysis/north-america-and-europe-pegylated-drugs-market
Chapter 3. North America & Europe PEGylated Drugs Industry Insights
3.1. Industry segmentation
3.2. Industry impact forces
3.2.1. Growth drivers
3.2.1.1. Increasing prevalence of cancer in developed regions
3.2.1.2. Rising R&D spending by biotechnology & pharmaceutical companies in U.S. and Europe
3.2.1.3. Growing biologics sector in the developed economies
Data Tables
TABLE 1. North America & Europe PEGylated drugs industry 3600 synopsis, 2013 – 2024
TABLE 2. Industry impact forces
TABLE 3. Cancer market size, by country, 2013 - 2024
TABLE 4. Hepatitis market size, by country, 2013 - 2024
TABLE 5. Multiple sclerosis market size, by country, 2013 - 2024
TABLE 6. Gastrointestinal disorders market size, by country, 2013 - 2024
TABLE 7. Others market size, by country, 2013 - 2024
TABLE 8. Monoclonal antibodies (mAbs) market size, by country, 2013 - 2024
TABLE 9. Colony stimulating factors market size, by country, 2013 - 2024
TABLE 10. Interferons market size, by country, 2013 - 2024
Related Report- Bariatric Surgery Devices Market Size, Industry Analysis Report, Regional Outlook, Application Development Potential, Price Trends, Competitive Market Share & Forecast
Know more@ https://www.marketwatch.com/press-release/bariatric-surgery-devices-market-to-surge-at-58-cagr-and-overtake-us-22-bn-by-2024-2019-05-10
Global Market Insights Inc. is a global market research and management consulting company catering to leading corporations, non-profit organizations, universities and government institutions. Our main goal is to assist and partner organizations to make lasting strategic improvements and realize growth targets. Our industry research reports are designed to provide granular quantitative information, combined with key industry insights, aimed at assisting sustainable organizational development.
Global Market Insights, Inc.
4 North Main Street
Selbyville, Delaware 19975 USA
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email:sales@gminsights.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release North America and Europe PEGylated Drugs Market 2018-2024| Key Players: Pfizer, Amgen, Biogen, Novo Nordisk here
News-ID: 1735334 • Views: …
More Releases from Global Market Insights Inc.
Latest Research Report On Agricultural Adjuvants Market 2021. Major Players Incl …
The agricultural adjuvants market is expected to observe noteworthy growth on account of increasing demand for high-quality crops. Adjuvants commonly act as an additive in pesticides that increase its effectiveness and smoothen its mixing application.
The demand for plant protection products in countries like Bangladesh, India, and Vietnam has surged considerably in recent years. Ever-increasing population across developing economies has forced farmers to produce large quantities of high-quality yields. Citing…
U.S. Minoxidil Market 2021 Growth Opportunities and Competitive Landscape 2027 - …
The U.S. minoxidil industry has been impacted by the COVID-19 pandemic in the form of increased stress amid job losses and health issues, creating rising incidences of hair fall and associated problems. The industry is expected to gain commendable proceeds on account of an upsurge in research studies concerned with the effectiveness of minoxidil.
Citing one such instance, in January 2021, a study published in the Dermatologic Therapy supported the efficacy…
Global Sulfosuccinate Market 2021 Future Growth With Technology and Current Tren …
Owing to these factors, estimates have revealed that the global sulfosuccinate market size will exceed USD 475.7 million in annual estimation by 2024.
Increasing adoption of high-performance materials that meet application-specific requirements across various industries, including pharmaceuticals will stimulate the need for sulfosuccinate compounds. The surging disposable incomes of consumers mainly across the developing nations have also fueled their spending capacities on household and personal care.
Sulfosuccinates are mainly a mild type…
By 2026, Graphene Market will register over 35% CAGR | Applied Nanotech, Inc, an …
The global Graphene Market is slated to gain significant momentum over the forthcoming years, as a result of the growing product consumption in the electronics sector, particularly in developing countries. This high consumption can be attributed to its superior qualities such as high electrical conductivity, durability, and toughness.
Request a sample of this research report @
https://www.gminsights.com/request-sample/detail/233
Top Key Players in The Market are:
Graphenea S.A., Applied Graphene Materials plc, ACS…
More Releases for PEGylated
PEGylated Proteins Market: Competitive Dynamics & Global Outlook 2023
New report published by Market Research Report Store (MRRS) which offers insights on the global PEGylated Proteins market.
PEGylating has been widely used as a post-production modification methodology for improving biomedical efficacy and physicochemical properties of therapeutic proteins since the first PEGylated product was approved by Food and Drug Administration in the early 1990s.
Click to view the full report TOC, figure and tables:
https://www.marketresearchreportstore.com/reports/2882/global-pegylated-proteins-market
Global PEGylated Proteins Market: Forecast by…
PEGylated Proteins Market Striking over 2024
Global PEGylated Proteins Market: Snapshot
The development of the healthcare industry and the introduction of new drugs and therapeutics are the key factors estimated to encourage the growth of the global PEGylated proteins market in the next few years. The rising number of lifestyle disorders and the growing demand for effective therapeutics are boosting the demand for PEGylated proteins. In addition, the increasing focus on research and developing activities and innovations…
PEGylated Proteins Market : Industry Perspective and Comprehensive Analysis 2024
Global PEGylated Proteins Market: Snapshot
The development of the healthcare industry and the introduction of new drugs and therapeutics are the key factors estimated to encourage the growth of the global PEGylated proteins market in the next few years. The rising number of lifestyle disorders and the growing demand for effective therapeutics are boosting the demand for PEGylated proteins. In addition, the increasing focus on research and developing activities and innovations…
PEGylated Proteins Market to See Incredible Growth
The process of chaining or modification of biological molecules by conjugation with non-immunogenic polymer and nontoxic polyethylene glycol to improve or modify the physicochemical property of molecule is known as PEGylation. PEGylation improves stability and solubility of drug and decreases immunogenicity by changing the electrostatic binding, confirmation, and hydrophobicity of the molecule. PEGylation decreases the dose frequency by reducing renal excretion and proteolysis, and increases tension time of conjugates in…
Segment-level analysis On PEGylated Proteins Market
Global PEGylated Proteins Market was worth USD 690.6 million in 2016 and estimated to be growing at a CAGR of 10.50%, to reach USD 1.137 billion by 2021.
The market is showing great potential in the forecast period, i.e. till 2021. PEGylation is a process of attachment of covalent or non-covalent bond of PolyEthylene Glucol (PEG) polymer chains to molecules and macrostructures, like protein in case of PEGylation of proteins.…
PEGylated Proteins 2024 Market Research Report
The process of chaining or modification of biological molecules by conjugation with non-immunogenic polymer and nontoxic polyethylene glycol to improve or modify the physicochemical property of molecule is known as PEGylation. PEGylation improves stability and solubility of drug and decreases immunogenicity by changing the electrostatic binding, confirmation, and hydrophobicity of the molecule. PEGylation decreases the dose frequency by reducing renal excretion and proteolysis, and increases tension time of conjugates in…
